Skip to main content
Livermore
Livermore
ZHEN

Geneva Partners, LLC

SEC CIK
0001712671
Latest filing
Aug 10, 2026

The latest 13F from Geneva Partners, LLC covers Q2 2026 (filed Aug 10, 2026): 75 long positions worth $375.1M. The top 10 holdings make up 41.1% of the portfolio, and the largest is Dell Technologies Inc. (DELL) at 5.4%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
18
Est. +$120.0M
Added
32
Est. +$22.5M
Reduced
22
Est. −$16.6M
Sold out
6
Est. −$18.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. DELLDell Technologies Inc.
    5.4%$20.3MHistory
  2. MRVLMarvell Technology, Inc.
    5.4%$20.3MHistory
  3. GOOGLAlphabet Inc.
    4.5%$16.9MHistory
  4. STRLSterling Infrastructure, Inc.
    4.5%$16.8MHistory
  5. State Street SPDR S&P Biotech ETF78464A870
    4.0%$15.0M

Biggest buys

New and added positions, by estimated amount bought

  1. MRVLMarvell Technology, Inc.
    +$20.3MNewHistory
  2. State Street SPDR S&P Biotech ETF78464A870
    +$15.0MNew
  3. TERTeradyne, Inc
    +$13.8MNewHistory
  4. GLWCorning Inc
    +$12.7MNewHistory
  5. AMATApplied Materials Inc
    +$11.9MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MRVLMarvell Technology, Inc.
    +5.40 pp0.0% → 5.4%History
  2. State Street SPDR S&P Biotech ETF78464A870
    +4.00 pp0.0% → 4.0%
  3. TERTeradyne, Inc
    +3.68 pp0.0% → 3.7%History
  4. GLWCorning Inc
    +3.38 pp0.0% → 3.4%History
  5. AMATApplied Materials Inc
    +3.16 pp0.0% → 3.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. Vanguard Health Care ETF92204A504
    −$8.04MSold out
  2. LLYEli Lilly & Co
    −$4.42MReducedHistory
  3. KLACKLA Corp
    −$3.60MReducedConverted for a 10-for-1 splitHistory
  4. ORLYO Reilly Automotive Inc
    −$3.49MSold outHistory
  5. HSYHershey Co
    −$2.69MSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. Vanguard Health Care ETF92204A504
    −3.86 pp3.9% → 0.0%
  2. NVDANVIDIA Corp
    −2.78 pp6.7% → 3.9%History
  3. AVGOBroadcom Inc.
    −1.85 pp4.6% → 2.8%History
  4. LLYEli Lilly & Co
    −1.80 pp2.3% → 0.5%History
  5. METAMeta Platforms, Inc.
    −1.80 pp3.2% → 1.4%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$375.1M
+$166.9M (+80.1%) vs. prior quarter
Positions
75
+12 vs. prior quarter
Top 10 concentration
41.1%
Top 10 as share of value
Turnover
11.9%
Q2 2026, one quarter
Average holding period
6.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $375.1M (Q2 2026)

Q1 2021: $193.4MQ2 2021: $218.5MQ3 2021: $202.7MQ4 2021: $200.9MQ1 2022: $161.8MQ2 2022: $101.7MQ3 2022: $87.5MQ4 2022: $105.9MQ1 2023: $116.9MQ2 2023: $153.3MQ3 2023: $150.7MQ4 2023: $180.5MQ1 2024: $226.6MQ2 2024: $242.8MQ3 2024: $231.0MQ4 2024: $246.3MQ1 2025: $194.0MQ2 2025: $252.0MQ3 2025: $273.6MQ4 2025: $280.8MQ1 2026: $208.2MQ2 2026: $375.1M
Q1 2021Q2 2026
13F filings of Geneva Partners, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 10, 202675$375.1MDELLMRVLGOOGLvs. Q1 2026SEC
Q1 2026Apr 29, 202663$208.2MNVDAGOOGLiShares Core S&P 500 ETFvs. Q4 2025SEC
Q4 2025Feb 3, 202669$280.8MGOOGLLLYNVDAvs. Q3 2025SEC
Q3 2025Nov 12, 202568$273.6MNVDAAVGOMETAvs. Q2 2025SEC
Q2 2025Aug 14, 202572$252.0MMETANVDAMSFTvs. Q1 2025SEC
Q1 2025Apr 30, 202560$194.0MAMZNNVDAMETAvs. Q4 2024SEC
Q4 2024Jan 27, 202571$246.3MAAPLNVDAAMZNvs. Q3 2024SEC
Q3 2024Oct 30, 202470$231.0MAAPLNVDAAVGOvs. Q2 2024SEC
Q2 2024Jul 22, 202465$242.8MNVDAAAPLGOOGLvs. Q1 2024SEC
Q1 2024Apr 30, 202466$226.6MMETAUBERNVDAvs. Q4 2023SEC
Q4 2023Jan 31, 202471$180.5MUBERMETAMSFTvs. Q3 2023SEC
Q3 2023Oct 25, 202362$150.7MMETAGOOGLUBERvs. Q2 2023SEC
Q2 2023Aug 3, 202373$153.3MMSFTiShares Core S&P 500 ETFNVDAvs. Q1 2023SEC
Q1 2023Apr 26, 202360$116.9MPEPiShares Core S&P 500 ETFMRKvs. Q4 2022SEC
Q4 2022Jan 23, 202354$105.9MPEPMRKLMTvs. Q3 2022SEC
Q3 2022Oct 31, 202255$87.5MPEPLMTELVvs. Q2 2022SEC
Q2 2022Jul 25, 202253$101.7MLMTCVXELVvs. Q1 2022SEC
Q1 2022May 3, 202274$161.8MGOOGLBRK.BCVXvs. Q4 2021SEC
Q4 2021Jan 31, 202295$200.9MiShares MSCI USA Quality Factor ETFGOOGLMSFTvs. Q3 2021SEC
Q3 2021Oct 18, 202186$202.7MGOOGLMSFTMETAvs. Q2 2021SEC
Q2 2021Aug 6, 202192$218.5MAMZNGOOGLMSFTvs. Q1 2021SEC
Q1 2021May 5, 202177$193.4MAMZNCATiShares Core MSCI Emerging Markets ETF–SEC